• لمحة موجزة
  • المؤهلات العلمية
  • ألخبرة العمليّة
  • ألإنجازات
  • إتصل بنا
Author Image

د. فادي فرحات

أحدث المقالات

  • Safety and efficacy of pazopanib as a second-line treatment and beyond for soft tissue sarcomas: A real-life tertiary-center experience in the MENA region
  • Impact and Cost-Effectiveness of Oncotype DX for Guiding Adjuvant Chemotherapy Decisions in Early Breast Cancer
  • Impact of Commercialized Genomic Tests on Adjuvant Treatment Decisions in Early Stage Breast Cancer Patients
  • Neoadjuvant chemotherapy and Avelumab in early stage resectable nonsmall cell lung cancer
  • Synchronous invasive ductal carcinoma of the breast and clear cell renal carcinoma with rare presentation and behavior: a case report with a literature review

أحدث التعليقات

    الأرشيف

    • مايو 2021
    • يناير 2021
    • نوفمبر 2020
    • أكتوبر 2020
    • سبتمبر 2020
    • يوليو 2020
    • مايو 2020
    • أبريل 2020
    • مارس 2020
    • فبراير 2020
    • يناير 2020
    • نوفمبر 2019
    • أكتوبر 2019
    • سبتمبر 2019
    • مايو 2019
    • فبراير 2019
    • ديسمبر 2018
    • نوفمبر 2018
    • يوليو 2018
    • يونيو 2018
    • أبريل 2018
    • مارس 2018
    • فبراير 2018
    • ديسمبر 2017
    • نوفمبر 2017
    • سبتمبر 2017
    • يوليو 2017
    • أبريل 2017
    • فبراير 2017
    • يناير 2017
    • ديسمبر 2016
    • أغسطس 2016
    • يونيو 2016
    • مايو 2016
    • أبريل 2016
    • ديسمبر 2015
    • أغسطس 2015
    • يناير 2015
    • نوفمبر 2014
    • مايو 2014
    • أكتوبر 2013
    • يوليو 2013
    • يناير 2013
    • ديسمبر 2012
    • نوفمبر 2012
    • أكتوبر 2012
    • سبتمبر 2012
    • فبراير 2012
    • ديسمبر 2011
    • نوفمبر 2011
    • أبريل 2011
    • أبريل 2010
    • مارس 2009
    • ديسمبر 2008
    • يونيو 2008
    • مايو 2008
    • أبريل 2008
    • فبراير 2008
    • يناير 2008
    • فبراير 2007
    • يناير 2007
    • يونيو 2006
    • يونيو 2004
    • أبريل 1997
    • فبراير 1997
    • أبريل 1996
    • مارس 1996
    • أغسطس 1995
    • يناير 1995
    • أكتوبر 1994
    • يوليو 1994
    • أبريل 1994
    • مارس 1994
    • يناير 1994
    • مارس 1993

    تصنيفات

    • 5 FU
    • acute myeloid leukemia
    • Adenocarcinoma
    • adenosarcoma
    • adjuvant
    • adolescents
    • Adriamycin
    • adult
    • adults
    • advanced
    • advanced melanoma
    • ADVANCED PANCREATIC CANCER
    • advanced prostate cancer
    • after
    • aimless
    • ALK
    • AML
    • amplification
    • anti-angiogenic
    • approach
    • Apropos
    • artery
    • Article
    • attitude
    • Avelumab
    • axillary
    • B-cell
    • based
    • bFGF
    • biomarkers
    • biopsy
    • Biosimilar
    • bleomycin
    • bone
    • Bone Marrow
    • botryoid rhabdomyosarcoma
    • BRAF
    • BRAF inhibitor
    • brain metastasis
    • breast
    • breast cancer
    • CA 19-9
    • Ca125
    • calcitriol
    • Cancer
    • capecitabine
    • carboplatin
    • carcinoma
    • case
    • case report
    • Case Series
    • castration-resistant
    • castration-resistant prostate cancer
    • CDK4
    • CDK4/6inhibitors
    • Celecoxib
    • cell
    • center
    • Central Macular Thickness
    • Chemotherapy
    • Chemotherapy-induced differentiation
    • children
    • chronic Dysphagia
    • Chronic Lymphocytic Leukemia
    • chronic myeloid leukemia
    • CISCA
    • cisplatin
    • CML
    • cohort
    • colon
    • combination
    • Commercialized
    • compounds
    • Comprehensive
    • Cost-Effectiveness
    • Covid19
    • CPT11
    • cross-sectional study
    • CT
    • Cutaneous
    • cyclophosphamide
    • cylindroma
    • Decision
    • Delayed
    • Descriptive Study
    • Desmoplastic
    • Desmoplastic small round cell tumor
    • Detection
    • developing country
    • Diagnostic
    • disorder
    • dissection
    • Docetaxel
    • down's
    • doxorubicin
    • Dysgeusia
    • early
    • Early-Stage Breast Cancer
    • effects
    • efficacy
    • EGFR
    • elderly
    • ENACT
    • entity
    • Epidemiology
    • Epidermal
    • Epithelioid sarcoma
    • estramustine
    • etoposide
    • experience
    • Expression
    • Fabry disease
    • family
    • FAP
    • febrile
    • first-line
    • first-line therapy
    • focus
    • FOLFIRINOX
    • FOLFOX-6
    • friend
    • front-line
    • gastric
    • gastric cancer
    • gastrointestinal tumors
    • gemcitabine
    • gene
    • Genomic
    • germ cell tumor
    • good-risk
    • growth factor
    • Gulf
    • haemochromatosis
    • Head and Neck
    • hematology
    • hepatectomy
    • Hepatoid
    • HER2-positive
    • High-dose
    • high-risk
    • highly
    • Hormonal Therapy
    • hormone
    • HRPC
    • Hypertension
    • ifosfamide
    • imatinib
    • immune checkpoint inhibitors
    • immuno-histochemistry
    • immunosuppression
    • immunotherapy
    • Impact
    • impella
    • inhibitors
    • Institut Gustave Roussy
    • Institutional
    • intra-abdominal desmoplastic small round-cell tumours
    • invasive ductal carcinoma
    • irinotecan
    • JAK2
    • kidney cancer
    • Kodamaea
    • KRAS
    • laboratory
    • Large B-Cell Lymphoma
    • last month
    • late
    • Lebanese
    • Lebanon
    • Levant countries
    • Limb
    • lipoplatin
    • Liposarcoma
    • liposomal cisplatin
    • literature
    • lithotomy
    • locally
    • locally advanced
    • long-term
    • LP 5.0 microaxial pump
    • Lung
    • Lung Cancer
    • Lymph Node Metastases
    • lymphoma
    • maintenance
    • major
    • malignant
    • manifestation
    • MEK inhibitions
    • melanoma
    • MENA
    • Mesotheliomas
    • metastatic
    • metastatic breast cancer
    • metastatic hormone-receptors positive breast cancer
    • metastatic pancreatic cancer
    • Metastatic Prostate Cancer
    • Metastatic Renal Cell Carcinoma
    • Middle East
    • Monitoring
    • mono-antibiotic
    • mustard
    • Mutation
    • Mutations
    • myeloproliferative
    • nationwide
    • navelbine
    • negative
    • Neoadjuvant
    • neuron-specific enolase
    • neutropenia
    • new
    • new challenge
    • Next-generation
    • nilotinib
    • non-seminomatous
    • non-small cell lung cancer
    • nonseminomatous germ cell tumors
    • nonseminomatous germ-cell tumors
    • North Africa
    • NRAS
    • NSCLC
    • nurse
    • Observational
    • ohmeri fungaemia
    • oncology
    • Oncotype DX
    • Opioid
    • Oral
    • Oral Dryness
    • Oral Mucositis
    • OSSMAR
    • Ovarian Cancer
    • Overview
    • paclitaxel
    • Pain
    • Palbociclib
    • palliative care
    • Pancreatic
    • Papillary Thyroid Carcinoma
    • Patient
    • patients
    • pazopanib
    • personalized therapy
    • PET
    • PET scan
    • phase 2
    • Phase II
    • Photobiomodulation
    • physician
    • pichia
    • PIK3R1
    • pilot
    • Pilot Study
    • piperacillin
    • platelet-to-lymphocyte ratio
    • platinum
    • poor response
    • poor risk
    • population
    • possibly
    • post tamoxifen
    • posture
    • predictive
    • premenopausal
    • preoperative therapy
    • prevalence
    • Primary
    • procedure
    • prognostic
    • prolonged
    • Prospective
    • prostate
    • prostate cancer
    • protocol
    • Radiotherapy
    • randomized
    • Rare
    • RB1
    • Real-Life
    • real-life experience
    • receptor
    • recommendations
    • recover
    • referral
    • refractory
    • relapse
    • relapsed
    • renal carcinoma
    • resistant
    • respiratory
    • rete testis
    • retroperitoneal lymph node
    • retrospective
    • review
    • rhabdomyolysis
    • Ribociclib
    • RICTOR gene
    • right
    • role
    • Rosai-Dorfman disease
    • round
    • safety
    • salvage
    • second-line
    • sequencing
    • sequential
    • series
    • severity
    • Side-Effects
    • Signet Ring cell carcinoma
    • small
    • small cell cancer
    • soft tissue sarcoma
    • solid
    • South Lebanon
    • spermatic cord
    • Stage II
    • Stomach
    • study
    • substandard medicines
    • sulbactam
    • sulfur
    • Sunitinib
    • surgery
    • surgical
    • symptoms
    • syndrome
    • tamoxifen
    • targeted
    • Taxane-Based Therapy
    • Therapeutic
    • therapy
    • Tongue
    • Toxicity
    • TP53
    • trastuzumab
    • treatment
    • trial
    • triple
    • triple-negative breast cancer
    • TRK
    • tumor
    • tumors
    • tumour markers
    • Uncategorized
    • urothelial
    • uterine müllerian
    • V617F
    • VAB-6
    • value
    • vancomycin
    • VEGF
    • vinblastine
    • vinorelbine
    • virus
    • Visually Asymptomatic Patients
    • weekly
    • woman
    • work-up
    • zolandronic acid
    • Zoledronic acid
    • zolendronic acid

    منوعات

    • تسجيل الدخول
    • خلاصات Feed الإدخالات
    • خلاصة التعليقات
    • WordPress.org
    د. فادي فرحات د. فادي فرحات
    • لمحة موجزة
    • المؤهلات العلمية
    • ألخبرة العمليّة
    • ألإنجازات
    • إتصل بنا
    11 يناير
    #adenosarcoma #breast cancer #case report #post tamoxifen #premenopausal #tamoxifen #uterine müllerian #woman

    A case of synchronous relapse of breast cancer and uterine müllerian adenosarcoma post tamoxifen in a premenopausal woman

    by Dr. Fadi Farhat 0
    02 فبراير
    #first-line #FOLFOX-6 #locally advanced #metastatic pancreatic cancer

    FOLFOX-6 combination as the first-line treatment of locally advanced and/or metastatic pancreatic cancer

    by Dr. Fadi Farhat 0
    12 يناير
    #CPT11 #gastric cancer #irinotecan #treatment

    A general review of the role of irinotecan (CPT11) in the treatment of gastric cancer

    by Dr. Fadi Farhat 0
    01 يونيو
    #capecitabine #first-line therapy #metastatic #metastatic breast cancer #phase 2 #Phase II #trial #vinorelbine

    Phase II trial of capecitabine and vinorelbine as first-line chemotherapy for metastatic breast cancer patients

    by Dr. Fadi Farhat 0
    01 يونيو
    #breast cancer #carboplatin #gemcitabine #relapsed #second-line

    Gemcitabine plus carboplatin combination therapy as second-line treatment in patients with relapsed breast cancer

    by Dr. Fadi Farhat 0
    14 أبريل
    #bleomycin #Chemotherapy #CISCA #cisplatin #cyclophosphamide #doxorubicin #etoposide #germ cell tumor #non-seminomatous #poor risk #vinblastine

    Experience with bleomycin, etoposide, cisplatin (BEP) and alternating cisplatin, cyclophosphamide, doxorubicin (CISCA(II))/vinblastine, bleomycin (VB(IV)) regimens of chemotherapy in poor-risk non-seminomatous germ cell tumors

    by Dr. Fadi Farhat 0
    08 أبريل
    #Chemotherapy #cohort #good-risk #long-term #metastatic #nonseminomatous germ-cell tumors #VAB-6

    Evaluation of long-term results of a modified VAB-6 chemotherapy regimen in a cohort of good-risk metastatic non seminomatous germ-cell tumors

    by Dr. Fadi Farhat 0
    02 فبراير
    #Ca125 #intra-abdominal desmoplastic small round-cell tumours #neuron-specific enolase #tumour markers

    Ca125 and neuron-specific enolase (NSE) as tumour markers for intra-abdominal desmoplastic small round-cell tumours

    by Dr. Fadi Farhat 0
    10 أبريل
    #adult #Chemotherapy #Desmoplastic small round cell tumor #Patient

    Desmoplastic small round cell tumors: results of a four-drug chemotherapy regimen in five adult patients

    by Dr. Fadi Farhat 0
    10 مارس
    #cisplatin #etoposide #germ cell tumor #ifosfamide #Institut Gustave Roussy #refractory #relapse #salvage #therapy #vinblastine

    Cisplatin and ifosfamide with either vinblastine or etoposide as salvage therapy for refractory or relapsing germ cell tumor patients: the Institut Gustave Roussy experience

    by Dr. Fadi Farhat 0
    1 … 7 8 9 10